MIO, Catia
MIO, Catia
DMED - DIPARTIMENTO DI MEDICINA
A bird’s eye view on the use of whole exome sequencing in rare congenital ophthalmic diseases
2024-01-01 Zucco, J.; Baldan, F.; Allegri, L.; Bregant, E.; Passon, N.; Franzoni, A.; D'Elia, A. V.; Faletra, F.; Damante, G.; Mio, C.
A novel de novo HDAC8 missense mutation causing Cornelia de Lange syndrome
2021-01-01 Mio, C.; Passon, N.; Fogolari, F.; Cesario, C.; Novelli, A.; Pittini, C.; Damante, G.
A novel de novo NIPA1 missense mutation associated to hereditary spastic paraplegia
2021-01-01 Fabbro, D.; Mio, C.; Fogolari, F.; Damante, G.
A paternally inherited 1.4 kb deletion of the 11p15.5 imprinting center 2 is associated with a mild familial Silver–Russell syndrome phenotype
2020-01-01 Mio, C.; Allegri, L.; Passon, N.; Bregant, E.; Demori, E.; Franzoni, A.; Driul, D.; Riccio, A.; Damante, G.; Baldan, F.
A polymorphic GGC repeat in the NPAS2 gene and its association with melanoma
2017-01-01 Franzoni, Alessandra; Markova-Car, Elitza; Dević-Pavlić, Sanja; Jurišić, Davor; Puppin, Cinzia; Mio, Catia; De Luca, Marila; Petruz, Giulia; Damante, Giuseppe; Pavelić, Sandra Kraljević
A Streamlined Approach to Rapidly Detect SARS-CoV-2 Infection Avoiding RNA Extraction: Workflow Validation
2020-01-01 Mio, C.; Cifu, A.; Marzinotto, S.; Bergamin, N.; Caldana, C.; Cattarossi, S.; Cmet, S.; Cussigh, A.; Martinella, R.; Zucco, J.; Verardo, R.; Schneider, C.; Marcon, B.; Zampieri, S.; Pipan, C.; Curcio, F.
Analysis of the biological mechanisms de-regulated after pharmacological BET inhibition in a model of anaplastic thyroid cancer
2017-03-29 Mio, Catia
BAZ1B is a candidate gene responsible for hypothyroidism in Williams syndrome
2020-01-01 Allegri, L.; Baldan, F.; Mio, C.; De Felice, M.; Amendola, E.; Damante, G.
BET bromodomain inhibitor JQ1 modulates microRNA expression in thyroid cancer cells
2018-01-01 Mio, Catia; Conzatti, Ketty; Baldan, Federica; Allegri, Lorenzo; Sponziello, Marialuisa; Rosignolo, Francesca; Russo, Diego; Filetti, Sebastiano; Damante, Giuseppe
BET proteins regulate homologous recombination-mediated DNA repair: BRCAness and implications for cancer therapy
2019-01-01 Mio, Catia; Gerratana, Lorenzo; Bolis, Marco; Caponnetto, Federica; Zanello, Andrea; Barbina, Mattia; Di Loreto, Carla; Garattini, Enrico; Damante, Giuseppe; Puglisi, Fabio
Biological and molecular effects of bromodomain and extra-terminal (BET) inhibitors JQ1, IBET-151, and IBET-762 in OSCC cells
2019-01-01 Baldan, Federica; Allegri, Lorenzo; Lazarevic, Milos; Mio, Catia; Milosevic, Maja; Damante, Giuseppe; Milasin, Jelena
Brain Endothelial Cells Activate Neuroinflammatory Pathways in Response to Early Cerebral Small Vessel Disease (CSVD) Patients’ Plasma
2023-01-01 Cifu', A.; Janes, F.; Mio, C.; Pessa, M. E.; Garbo, R.; Curcio, F.; Valente, M.; Fabris, M.; Domenis, R.
CACNA1C haploinsufficiency accounts for the common features of interstitial 12p13.33 deletion carriers
2020-01-01 Mio, C.; Passon, N.; Baldan, F.; Bregant, E.; Monaco, E.; Mancini, L.; Demori, E.; Damante, G.
Challenges in promoter methylation analysis in the new era of translational oncology: a focus on liquid biopsy
2022-01-01 Mio, C.; Damante, G.
Correction to: Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinoma (Endocrine, (2020), 10.1007/s12020-020-02221-8)
2020-01-01 Falcone, R.; Sponziello, M.; Carletti, R.; Di Gioia, C.; Nardi, F.; Mio, C.; Pecce, V.; Abballe, L.; Grani, G.; Ramundo, V.; Damante, G.; Durante, C.; Filetti, M.; Roberto, M.; Marchetti, P.; Verrienti, A.
Effects of BP-14, a novel cyclin-dependent kinase inhibitor, on anaplastic thyroid cancer cells
2016-01-01 Allegri, Lorenzo; Baldan, Federica; Mio, Catia; Puppin, Cinzia; Russo, Diego; Kry͉tof, Vladimir; Damante, Giuseppe
Effects of HuR downregulation on anaplastic thyroid cancer cells
2018-01-01 Allegri, L.; Mio, C.; Russo, D.; Filetti, S.; Baldan, F.
Effects of nutraceuticals on anaplastic thyroid cancer cells
2018-01-01 Allegri, Lorenzo; Rosignolo, Francesca; Mio, Catia; Baldan, Federica; Damante, Giuseppe; Filetti, Sebastiano
Epigenetic bivalent marking is permissive to the synergy of HDAC and PARP inhibitors on TXNIP expression in breast cancer cells
2015-01-01 Baldan, Federica; Mio, Catia; Lavarone, Elisa; DI LORETO, Carla; Puglisi, Fabio; Damante, Giuseppe; Puppin, Cinzia
Evaluation of somatic genomic imbalances in thyroid carcinomas of follicular origin by CGH-based approaches
2018-01-01 Baldan, Federica; Mio, Catia; Allegri, Lorenzo; Passon, Nadia; Lepore, Saverio M.; Russo, Diego; Damante, Giuseppe
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A bird’s eye view on the use of whole exome sequencing in rare congenital ophthalmic diseases | 1-gen-2024 | Zucco, J.; Baldan, F.; Allegri, L.; Bregant, E.; Passon, N.; Franzoni, A.; D'Elia, A. V.; Faletra, F.; Damante, G.; Mio, C. | |
| A novel de novo HDAC8 missense mutation causing Cornelia de Lange syndrome | 1-gen-2021 | Mio, C.; Passon, N.; Fogolari, F.; Cesario, C.; Novelli, A.; Pittini, C.; Damante, G. | |
| A novel de novo NIPA1 missense mutation associated to hereditary spastic paraplegia | 1-gen-2021 | Fabbro, D.; Mio, C.; Fogolari, F.; Damante, G. | |
| A paternally inherited 1.4 kb deletion of the 11p15.5 imprinting center 2 is associated with a mild familial Silver–Russell syndrome phenotype | 1-gen-2020 | Mio, C.; Allegri, L.; Passon, N.; Bregant, E.; Demori, E.; Franzoni, A.; Driul, D.; Riccio, A.; Damante, G.; Baldan, F. | |
| A polymorphic GGC repeat in the NPAS2 gene and its association with melanoma | 1-gen-2017 | Franzoni, Alessandra; Markova-Car, Elitza; Dević-Pavlić, Sanja; Jurišić, Davor; Puppin, Cinzia; Mio, Catia; De Luca, Marila; Petruz, Giulia; Damante, Giuseppe; Pavelić, Sandra Kraljević | |
| A Streamlined Approach to Rapidly Detect SARS-CoV-2 Infection Avoiding RNA Extraction: Workflow Validation | 1-gen-2020 | Mio, C.; Cifu, A.; Marzinotto, S.; Bergamin, N.; Caldana, C.; Cattarossi, S.; Cmet, S.; Cussigh, A.; Martinella, R.; Zucco, J.; Verardo, R.; Schneider, C.; Marcon, B.; Zampieri, S.; Pipan, C.; Curcio, F. | |
| Analysis of the biological mechanisms de-regulated after pharmacological BET inhibition in a model of anaplastic thyroid cancer | 29-mar-2017 | Mio, Catia | |
| BAZ1B is a candidate gene responsible for hypothyroidism in Williams syndrome | 1-gen-2020 | Allegri, L.; Baldan, F.; Mio, C.; De Felice, M.; Amendola, E.; Damante, G. | |
| BET bromodomain inhibitor JQ1 modulates microRNA expression in thyroid cancer cells | 1-gen-2018 | Mio, Catia; Conzatti, Ketty; Baldan, Federica; Allegri, Lorenzo; Sponziello, Marialuisa; Rosignolo, Francesca; Russo, Diego; Filetti, Sebastiano; Damante, Giuseppe | |
| BET proteins regulate homologous recombination-mediated DNA repair: BRCAness and implications for cancer therapy | 1-gen-2019 | Mio, Catia; Gerratana, Lorenzo; Bolis, Marco; Caponnetto, Federica; Zanello, Andrea; Barbina, Mattia; Di Loreto, Carla; Garattini, Enrico; Damante, Giuseppe; Puglisi, Fabio | |
| Biological and molecular effects of bromodomain and extra-terminal (BET) inhibitors JQ1, IBET-151, and IBET-762 in OSCC cells | 1-gen-2019 | Baldan, Federica; Allegri, Lorenzo; Lazarevic, Milos; Mio, Catia; Milosevic, Maja; Damante, Giuseppe; Milasin, Jelena | |
| Brain Endothelial Cells Activate Neuroinflammatory Pathways in Response to Early Cerebral Small Vessel Disease (CSVD) Patients’ Plasma | 1-gen-2023 | Cifu', A.; Janes, F.; Mio, C.; Pessa, M. E.; Garbo, R.; Curcio, F.; Valente, M.; Fabris, M.; Domenis, R. | |
| CACNA1C haploinsufficiency accounts for the common features of interstitial 12p13.33 deletion carriers | 1-gen-2020 | Mio, C.; Passon, N.; Baldan, F.; Bregant, E.; Monaco, E.; Mancini, L.; Demori, E.; Damante, G. | |
| Challenges in promoter methylation analysis in the new era of translational oncology: a focus on liquid biopsy | 1-gen-2022 | Mio, C.; Damante, G. | |
| Correction to: Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinoma (Endocrine, (2020), 10.1007/s12020-020-02221-8) | 1-gen-2020 | Falcone, R.; Sponziello, M.; Carletti, R.; Di Gioia, C.; Nardi, F.; Mio, C.; Pecce, V.; Abballe, L.; Grani, G.; Ramundo, V.; Damante, G.; Durante, C.; Filetti, M.; Roberto, M.; Marchetti, P.; Verrienti, A. | |
| Effects of BP-14, a novel cyclin-dependent kinase inhibitor, on anaplastic thyroid cancer cells | 1-gen-2016 | Allegri, Lorenzo; Baldan, Federica; Mio, Catia; Puppin, Cinzia; Russo, Diego; Kry͉tof, Vladimir; Damante, Giuseppe | |
| Effects of HuR downregulation on anaplastic thyroid cancer cells | 1-gen-2018 | Allegri, L.; Mio, C.; Russo, D.; Filetti, S.; Baldan, F. | |
| Effects of nutraceuticals on anaplastic thyroid cancer cells | 1-gen-2018 | Allegri, Lorenzo; Rosignolo, Francesca; Mio, Catia; Baldan, Federica; Damante, Giuseppe; Filetti, Sebastiano | |
| Epigenetic bivalent marking is permissive to the synergy of HDAC and PARP inhibitors on TXNIP expression in breast cancer cells | 1-gen-2015 | Baldan, Federica; Mio, Catia; Lavarone, Elisa; DI LORETO, Carla; Puglisi, Fabio; Damante, Giuseppe; Puppin, Cinzia | |
| Evaluation of somatic genomic imbalances in thyroid carcinomas of follicular origin by CGH-based approaches | 1-gen-2018 | Baldan, Federica; Mio, Catia; Allegri, Lorenzo; Passon, Nadia; Lepore, Saverio M.; Russo, Diego; Damante, Giuseppe |